NCT06190470

Effects of Marijuana on Neuropathic Pain and Spasticity in Spinal Cord Injury Patients

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Khon Kaen University · Academic / Other
• Sex: All
• Age: 25 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to compare effects of marijuana or cannabis on neuropathic pain and spasticity in spinal cord injury patients. The main question is: Does the cannabis product from KhonKaen University reduce neuropathic pain and spasticity in spinal cord injury patients? The research design is a crossover study. The participants will be randomly into 2 groups: group 1 and group 2. The participants received either cannabis or placebo for 2 weeks. After completing treatment, participants were swapped to the other group for 2 weeks, a wash-out period is 2 weeks. The outcome measurements are pain and spasticity.

Conditions

• Spinal Cord Injury

Interventions

Type	Name	Description
DRUG	Cannabis	Cannabis product is from the extraction of the powdered, dried and mature pistillate inflorescences of Cannabis sativa L. containing THC 30mg/ml.
DRUG	Placebo	Placebo is similar to Cannabis product but do not contain THC.

Timeline

• Start date: 2024-01-02
• Primary completion: 2024-06-30
• Completion: 2024-06-30
• First posted: 2024-01-05
• Last updated: 2024-03-08

Locations

1 site across 1 country: Thailand